These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9727563)

  • 1. Cytotoxic T-cell responses to HIV-1 reverse transcriptase, integrase and protease.
    Haas G; Samri A; Gomard E; Hosmalin A; Duntze J; Bouley JM; Ihlenfeldt HG; Katlama C; Autran B
    AIDS; 1998 Aug; 12(12):1427-36. PubMed ID: 9727563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
    Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 Pol epitopes.
    Mason RD; Bowmer MI; Howley CM; Gallant M; Myers JC; Grant MD
    J Immunol; 2004 Jun; 172(11):7212-9. PubMed ID: 15153547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS; Tomiyama H; Inagawa T; Ida S; Oka S; Takiguchi M
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):503-10. PubMed ID: 12882660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
    Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
    AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens.
    Bolesta E; Gzyl J; Wierzbicki A; Kmieciak D; Kowalczyk A; Kaneko Y; Srinivasan A; Kozbor D
    Virology; 2005 Feb; 332(2):467-79. PubMed ID: 15680412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
    Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.
    Rowland-Jones SL; Dong T; Fowke KR; Kimani J; Krausa P; Newell H; Blanchard T; Ariyoshi K; Oyugi J; Ngugi E; Bwayo J; MacDonald KS; McMichael AJ; Plummer FA
    J Clin Invest; 1998 Nov; 102(9):1758-65. PubMed ID: 9802890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
    van der Burg SH; Klein MR; van de Velde CJ; Kast WM; Miedema F; Melief CJ
    AIDS; 1995 Feb; 9(2):121-7. PubMed ID: 7536421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase (review).
    Menéndez-Arias L; Mas A; Domingo E
    Viral Immunol; 1998; 11(4):167-81. PubMed ID: 10189185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in Gp160 and reverse transcriptase.
    Lieberman J; Fabry JA; Kuo MC; Earl P; Moss B; Skolnik PR
    J Immunol; 1992 May; 148(9):2738-47. PubMed ID: 1374097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
    J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of HLA-B*5401-restricted HIV-1-Nef and Pol-specific CTL epitopes.
    Kitano M; Kobayashi N; Kawashima Y; Akahoshi T; Nokihara K; Oka S; Takighuchi M
    Microbes Infect; 2008 Jun; 10(7):764-72. PubMed ID: 18538615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocytes response to HIV type 1 in an infected individual.
    Lieberman J; Fabry JA; Fong DM; Parkerson GR
    AIDS Res Hum Retroviruses; 1997 Mar; 13(5):383-92. PubMed ID: 9075479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.
    McKinney DM; Skvoretz R; Livingston BD; Wilson CC; Anders M; Chesnut RW; Sette A; Essex M; Novitsky V; Newman MJ
    J Immunol; 2004 Aug; 173(3):1941-50. PubMed ID: 15265928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDS.
    van der Burg SH; Klein MR; Pontesilli O; Holwerda AM; Drijfhout JW; Kast WM; Miedema F; Melief CJ
    J Immunol; 1997 Oct; 159(7):3648-54. PubMed ID: 9317165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Effects of Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Cytotoxic T Lymphocyte Recognition between HIV-1 Subtype B and Subtype A/E Infections.
    Kuse N; Rahman MA; Murakoshi H; Tran GV; Chikata T; Koyanagi M; Nguyen KV; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2015 Jul; 89(14):7363-72. PubMed ID: 25972553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice.
    Schönbach C; Nokihara K; Bangham CR; Kariyone A; Karaki S; Shida H; Takatsu K; Egawa K; Wiesmüller KH; Takiguchi M
    Virology; 1996 Dec; 226(1):102-12. PubMed ID: 8941327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulnerable targets in HIV-1 Pol for attenuation-based vaccine design.
    Ojwach DBA; Madlala P; Gordon M; Ndung'u T; Mann JK
    Virology; 2021 Feb; 554():1-8. PubMed ID: 33316731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.